valproic acid has been researched along with olanzapine in 191 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (1.05) | 18.2507 |
| 2000's | 107 (56.02) | 29.6817 |
| 2010's | 65 (34.03) | 24.3611 |
| 2020's | 17 (8.90) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y | 1 |
| DeGolia, SG; Dunai, M; Ketter, TA; Strong, CM; Tate, DL; Winsberg, ME | 1 |
| Grundy, S; Tohen, M | 1 |
| Chang, KD; Ketter, TA | 1 |
| Finkel, J; Hird, S; Solhkhah, R | 1 |
| DeVaney, GT; Grove, VE; Quintanilla, J | 1 |
| Ghaemi, SN; Guille, C; Sachs, GS | 1 |
| Nemeroff, CB | 1 |
| Ghaemi, SN | 1 |
| Gundlapalli, SP; Iqbal, MM; Passman, TE; Ryals, T; Ryan, WG | 1 |
| Grace, JJ; Narendran, R; Pato, MT; Pristach, CA; Valenti, AM; Young, CM | 1 |
| Baker, RW; Bowden, CL; Breier, A; Calabrese, JR; Chengappa, KN; Feldman, PD; Keeter, EL; Kupfer, DJ; Risser, RC; Sachs, GS; Suppes, T; Tohen, M; Tollefson, GD; Zarate, CA | 1 |
| Meyer, JM | 1 |
| Altshuler, LL; Baker, RW; Breier, A; Gilmore, JA; Ketter, TA; Milton, DR; Risser, R; Suppes, T; Tohen, M; Tollefson, GA; Zarate, CA | 1 |
| Abulseoud, O; Castelo, C; Kingsbury, SJ | 1 |
| Fernandez-Corres, B; Gonzalez-Pinto, A; Gutierrez, M; Lalaguna, B; Micó, JA; Pérez-Heredia, JL; Tohen, M | 1 |
| Ingram, W; Mann, JR; Olson, DA | 1 |
| Casey, DE; Daniel, DG; Sommerville, KW; Tracy, KA; Wassef, AA; Wozniak, P | 1 |
| Good, CR; Krecko, VF; Petersen, CA | 1 |
| Sachs, G; Sommerville, KW; Swann, AC; Weisler, R; Wozniak, P; Zajecka, JM | 1 |
| Altshuler, LL; Frye, MA; Gitlin, MJ | 1 |
| Shelton, RC | 1 |
| Keck, PE | 1 |
| Maguire, GA; Phillips, G | 1 |
| Paramore, LC; Revicki, DA; Sommerville, KW; Swann, AC; Zajecka, JM | 1 |
| Chen, PS; Lo, YC; Wang, YT; Yang, YK; Yeh, TL | 1 |
| Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
| Altshuler, L; Baker, RW; Brown, E; Frye, M; Ketter, TA; Risser, RC; Schuh, LM; Suppes, T; Tohen, M; Zajecka, J; Zarate, CA | 1 |
| Iwazaki, H | 1 |
| Basile, VS; Kennedy, SH; Mancini, DA; McIntyre, RS; Srinivasan, J | 1 |
| Baker, JD; Hirschfeld, RM; Sommerville, KW; Tracy, K; Wozniak, P | 1 |
| Arguisola, MS; Tavakoli, SA | 1 |
| Isaac, MB; Isaac, MT | 1 |
| Gonzalez-Heydrich, J; Leichtner, A; Mezzacappa, E; Raches, D; Wilens, TE | 1 |
| Dittmann, S; Grunze, H | 1 |
| Vieta, E | 1 |
| Hilligoss, NM; Johnson, CG; Kirshner, CD; Littrell, KH; Petty, RG | 1 |
| Casey, DE; Citrome, L; Daniel, DG; Kochan, LD; Tracy, KA; Wozniak, P | 1 |
| Baker, RW; Bowden, CL; Calabrese, JR; Chengappa, KN; Evans, AR; Feldman, PD; Ghaemi, SN; Kupfer, DJ; Risser, RC; Sachs, GS; Suppes, T; Tohen, M; Zarate, CA | 1 |
| Bagnall, AM; Bridle, C; Darba, J; Duffy, S; Palmer, S; Riemsma, R; Sculpher, M | 1 |
| Kass, E; Klein, RM; Lewis, FT | 1 |
| Ghaemi, SN; Hsu, DJ; Pardo, TB | 1 |
| Cramer, JA; Sernyak, M | 1 |
| Salerian, AJ | 1 |
| Breier, A; Namjoshi, MA; Risser, R; Shi, L; Tohen, M | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Oral, ET; Vahip, S | 1 |
| Kennedy, SH; Konarski, JZ; Mancini, DA; McCann, S; McIntyre, RS; Srinivasan, J | 1 |
| Schatzberg, AF | 1 |
| Akiskal, HS; Baker, RW; Brown, E; Calabrese, JR; Ketter, TA; Schuh, LM; Tohen, M; Trzepacz, PT; Watkin, JG | 1 |
| Connemann, BJ; Freudenmann, RW; Kassubek, J; Schönfeldt-Lecuona, C; Tumani, H | 1 |
| Baker, S; Braunstein, D; Casadonte, P; Hitzemann, R; Majewska, D; Montgomery, A; Reid, MS; Robinson, J; Rotrosen, J; Sanfilipo, M | 1 |
| Curtis, V | 1 |
| Findling, RL | 1 |
| Baker, RW; Lage, MJ; Shi, L; Tohen, M; Tunis, SL; Zhao, Z; Zhu, B | 1 |
| Alda, M; Baruch, P; Beaulieu, S; Connolly, M; Daigneault, A; Gorman, CP; Kennedy, SH; MacQueen, G; McIntyre, R; Milev, R; O'Donovan, C; Parikh, S; Ravindran, A; Schaffer, A; Sharma, V; Silverstone, P; Yatham, LN; Young, LT | 1 |
| Canonico, PL; Colella, L; Dellarole, A; Ferri, S; Ghi, P; Orsetti, M | 1 |
| Cho, SC; Chungh, DS; Kim, BN | 1 |
| Raskind, MA; Rosin, RA | 1 |
| Andrews, G; Page, AC | 1 |
| Geddes, J | 1 |
| Danielyan, A; Kowatch, RA | 1 |
| Baker, RW; Brown, E; Schuh, LM; Suppes, T; Tohen, M | 1 |
| Bräunig, P; Krüger, S; Young, T | 1 |
| Awad, AG | 1 |
| Canonico, PL; Colella, L; Dellarole, A; Ghi, P; Orsetti, M | 1 |
| Ginsberg, LD | 1 |
| Abu-Tair, F; Bergemann, N; Frick, A; Kopitz, J; Kress, KR | 1 |
| Cipriani, A; Geddes, JR; Rendell, JM | 1 |
| Ahl, J; Baldessarini, RJ; Houston, JP; Kaiser, CJ; Meyers, AL; Tohen, M | 1 |
| Atagun, I; Kaya, MC; Kurt, E; Oral, ET; Savas, E; Savas, HA; Selek, S; Yumru, M | 1 |
| Chou, JC; Fazzio, L | 1 |
| Albert, U; Bogetto, F; Maina, G; Mancini, M; Salvi, V | 1 |
| Beaulieu, S; Kennedy, SH; MacQueen, G; McIntyre, RS; O'Donovan, C; Parikh, SV; Sharma, V; Yatham, LN | 1 |
| Burke, RS; Parker, JD; Reeves, RR | 1 |
| Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J | 1 |
| Alda, M; Duffy, A; Garnham, J; Macdougall, M; Munro, A; O'Donovan, C; Passmore, M; Slaney, C; Teehan, A | 1 |
| Joo, YH; Kim, B; Kim, SJ; Son, JI | 1 |
| Brodaty, H; Cumming, R; Forrester, L; Grayson, D; Hollis, J; Touyz, S | 2 |
| Binder, CE; Fallu, A; Yatham, LN | 1 |
| Berk, M; Brnabic, A; de Castella, AR; Dodd, S; Fitzgerald, PB; Granger, RE; Kelin, K; Kulkarni, J; Montgomery, W | 1 |
| Barbieri, M; Beynon, S; Bravo Vergel, Y; Duffy, S; Dunn, G; Geddes, J; Gilbody, S; Palmer, S; Soares-Weiser, K; Woolacott, N | 1 |
| Aichhorn, W; Hinterhuber, H; Kemmler, G; Marksteiner, J; Stuppaeck, C; Walch, T; Zernig, G | 1 |
| Chen, G; Creson, TK; Engel, SR; Hao, Y; Landreth, GE; Maeng, S; Manji, HK; Nekrasova, T; Shen, Y | 1 |
| Berk, M; Dodd, S; Lubman, DI; Ng, F; Tohen, M; Vieta, E; Wang, WV | 1 |
| Cutler, AJ; El-Mallakh, RS; Gazda, T; Hirschfeld, R; Kalali, AH; Keck, P; Ketter, TA; Swann, AC; Weisler, RH | 1 |
| Barzman, DH; Findling, RL | 1 |
| Botts, S; Castro, FE; Cogollo, M; de Leon, J; Diaz, FJ; Muscatello, MR; Santoro, V; Spina, E | 1 |
| Bahk, WM; Cho, HS; Chung, SK; Ha, K; Jon, DI; Kim, W; Lee, E; Min, KJ; Seo, JS; Shin, YC; Yoon, BH | 1 |
| Costa, E; Dong, E; Grayson, DR; Guidotti, A; Nelson, M | 1 |
| Aaronson, ST; Amsterdam, JD; Banov, M; Bardenstein, L; Bowden, C; Goodwin, GM; Grecu-Gabos, I; Kryzhanovskaya, L; Oliff, HS; Prelipceanu, D; Shekhar, A; Sun, B; Tochilov, V; Tohen, M; Vieta, E | 1 |
| Bielecka-Grzela, S; Kacalak-Rzepka, A; Kiedrowicz, M; Maleszka, R; Mikulska, D; Ratajczak-Stefanska, V | 1 |
| Abi-Saab, W; Baker, J; Casey, DE; Daniel, DG; Greco, N; Kane, JM; Redden, L; Saltarelli, M; Tamminga, C; Tran-Johnson, T; Wozniak, P | 1 |
| Bini, P; Costa, A; Moglia, A; Montalbetti, L; Ratti, MT; Tosca, P; Uggetti, C | 1 |
| Cipriani, A; Geddes, J; Rendell, JM | 1 |
| Khalid, I; Khalid, TJ; Rana, L; Roehrs, T | 1 |
| Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM | 1 |
| Bertsch, J; Gonzalez-Pinto, A; Haro, JM; Novick, D; Perrin, E; Reed, C; Tohen, M | 1 |
| Fajutrao, L; Liu, S; Locklear, J; Paulsson, B | 1 |
| Degenhardt, EK; Houston, JP; Jamal, HH; Ketter, TA; Liu, LL; Tohen, M | 1 |
| Cipriani, A; Geddes, JR; Rendell, J | 1 |
| D'Arrigo, C; de Leon, J; Diaz, FJ; Muscatello, MR; Pandolfo, G; Santoro, V; Spina, E; Zoccali, R | 1 |
| Bond, DJ; Kauer-Sant'Anna, M; Lam, RW; Yatham, LN | 1 |
| Goldberg, JF | 1 |
| Bowden, C; Goodwin, GM; Grunze, H; Kasper, S; Licht, RW; Möller, HJ; Vieta, E | 1 |
| Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J | 1 |
| Badr, MG; D'yachkova, Y; Dikeos, D; Fábián, Z; Harrison, G; Hudiţă, C; Okasha, T; Pesek, MB; Tapia-Paniagua, G; Treuer, T; Yang, F | 1 |
| Bowden, C; Case, M; Degenhardt, EK; Houston, JP; Jamal, HH; Ketter, TA; Tohen, M | 1 |
| Fisar, Z; Hroudova, J | 1 |
| Lazarus, A; Quon, P; Tafesse, E; Woodward, TC | 1 |
| Gupta, M; Jiloha, RC; Kumar, A; Tekur, U | 1 |
| de Leon, J; Diaz, FJ; Spina, E | 1 |
| Calabrese, JR; Frye, MA; Ketter, TA; Tiller, JM; Yang, R; Youakim, JM | 1 |
| Glue, P; Herbison, P; Tarr, GP | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Blažević-Zelić, S; Peitl, MV; Peitl, V; Prološčić, J; Skarpa-Usmiani, I | 1 |
| Di Cosimo, D; Girardi, N; Kotzalidis, GD; Lazanio, S; Manfredi, G; Savoja, V; Talamo, A; Tatarelli, R; Vento, A | 1 |
| Bobo, WV; Bonaccorso, S; Chen, Y; Jayathilake, K; Meltzer, HY | 1 |
| Degenhardt, EK; Gatz, JL; Jacob, J; Tohen, M | 1 |
| Hayes, J; King, M; Nazareth, I; Osborn, D; Petersen, I; Prah, P; Walters, K | 1 |
| Blow, FC; Chiang, C; Cunningham, F; Kales, HC; Kim, HM; Schneider, LS; Seyfried, LS; Valenstein, M; Zivin, K | 1 |
| Chien, YL; Lin, YH | 1 |
| Higuchi, T; Kanba, S; Katagiri, H; Takahashi, M; Takita, Y; Tohen, M | 1 |
| Brisou, P; Emile, L; Gaillard, T; Gonzva, J; Pons, S; Prunet, B; Vest, P | 1 |
| Bhalerao, S; Chiang, C; Kales, HC; Kavanagh, J; Kim, HM; Seyfried, LS | 1 |
| Haslemo, T; Lunde, H; Molden, E; Olsen, K | 1 |
| Berk, L; Berk, M; Brnabic, AJ; de Castella, A; Dodd, S; Filia, K; Filia, S; Fitzgerald, PB; Kelin, K; Kulkarni, J; Lowry, AJ; Montgomery, W | 1 |
| Carroll, BT; Crosby, D; Peterson, J | 1 |
| Chen, CC; Chen, WJ; Kuo, CJ; Liao, YT; Liu, HC; Yang, SY | 1 |
| Ala, S; Farnia, S; Sheikhmoonesi, F; Yazdani, J; Zarghami, M | 1 |
| Baumann, P; Greil, W; Grohmann, R; Häberle, A; Schuhmann, T | 1 |
| Bahk, WM; Kim, MD; Kwon, YJ; Lee, HB; Lee, JG; Woo, YS; Yoon, BH | 1 |
| Cipriani, A; Geddes, J; Macritchie, K; Reid, K; Young, AH | 1 |
| Carlo, S; Castaing-Lespier, PA; Sabaté, N; Santos-Cubiñá, J; Torres-Martin, A; Torres-Rodríguez, A | 1 |
| Mifsud, J; Vella, T | 1 |
| Chauhan, S; Goyal, P; Kumar, D; Tripathi, P | 1 |
| Junewar, V; Rathaur, BP; Verma, R | 1 |
| Ambaliya, A; Dosi, R; Joshi, H; Patell, R | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Adali, I; Asri, F; Benali, A; Manoudi, F; Nabih, FO | 1 |
| Espinosa, JL; Martinez Miguel, P; Rodriguez Puyol, D; Samillán, K; Sencion Martinez, GL; Villa, P | 1 |
| Hara, H; Ishisaka, M; Mizoguchi, T; Shimazawa, M; Tsujii, S; Tsuruma, K | 1 |
| Barnhorst, A; Xiong, GL | 1 |
| Fusté, M; Gill, G; Haro, JM; Meléndez-Pérez, I; Pinacho, R; Ramos, B; Saia, G; Villalta-Gil, V | 1 |
| Joyce, DW; Mateos Fernandez, MJ; Sarkar, SN; Shergill, SS; Tracy, DK | 1 |
| Amerio, A; Ghaemi, SN; Odone, A; Stubbs, B; Tonna, M | 1 |
| Karanti, A; Kardell, M; Landén, M; Lundberg, U | 1 |
| Geddes, JR; Hayes, JF; King, M; Marston, L; Osborn, DP; Pitman, A; Walters, K | 1 |
| Geddes, JR; Hayes, JF; King, M; Marston, L; Osborn, DP; Walters, K | 1 |
| Rogers, J; Taylor, MJ | 1 |
| Andersen, M; Bodén, R; Brandt, L; Kieler, H; Reutfors, J; Tanskanen, A; Tiihonen, J; Wingård, L | 1 |
| B C, M; Chatterjee, SS; Das, S; Palappallil, DS | 1 |
| Bharadwaj, B; Kuppili, PP; Penchilaiya, V; Preeti, K | 1 |
| Ajayi, OO; Holroyd, S | 1 |
| Nurchi, AM; Pinna, AP; Podda, F; Ripoli, C; Tronci, MG; Zanni, R | 1 |
| Alda, M; Beaulieu, S; Berk, M; Bond, DJ; Calabrese, JR; Frey, BN; Goldstein, BI; Kanba, S; Kapczinski, F; Kennedy, SH; Kozicky, J; Lafer, B; Lam, RW; MacQueen, G; Malhi, G; McIntosh, D; McIntyre, RS; Milev, RV; O'Donovan, C; Parikh, SV; Post, RM; Ravindran, A; Rej, S; Schaffer, A; Sharma, V; Suppes, T; Vazquez, G; Vieta, E; Yatham, LN | 1 |
| Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH | 1 |
| Choy, KW; Drummer, OH; Pope, JD; Schneider, HG | 1 |
| Benyamina, A; Martelli, C; Petillion, A; Roméo, B | 1 |
| Graham, C; Sun, L; von Moltke, L; Yagoda, S; Yao, B | 1 |
| Chachar, AS; Mansoor, M; Mesiya, MH | 1 |
| Chen, HZ; Deng, SH; Hu, JQ; Li, L; Lu, HY; Ni, XJ; Qiu, C; Shang, DW; Wang, ZZ; Wen, YG; Xie, HS; Zhang, M; Zhu, XQ | 1 |
| Kawada, T | 1 |
| Bauer, M; Bohlken, J; Kostev, K; Riedel-Heller, S | 1 |
| Parmeggiani, A; Pruccoli, J | 1 |
| Chua, CJM; Nair, SS; Teo, DCL | 1 |
| Alda, M; Beaulieu, S; Berk, M; Bond, DJ; Calabrese, J; Chakrabarty, T; Frey, BN; Goldstein, BI; Kanba, S; Kapczinski, F; Kauer-Sant'Anna, M; Kennedy, SH; Kozicky, JM; Lam, RW; Malhi, G; McIntyre, RS; Milev, RV; O'Donovan, C; Parikh, SV; Post, R; Ravindran, AV; Rej, S; Schaffer, A; Sharma, V; Suppes, T; Tourjman, V; Vazquez, G; Vieta, E; Yatham, LN | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
| Ju, X; Li, J; Liu, J; Shi, J; Song, M; Wang, C; Wang, S; Yan, P | 1 |
| Roosen, L; Sienaert, P | 1 |
| Altunkaynak, Z; Bilgici, B; Gümrükçüoğlu, Tİ; Karaustaoğlu, A; Tunçel, ÖK | 1 |
| Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
| Hefner, G; Klimke, A; Reißner, P; Toto, S; Wolff, J | 1 |
| Hu, JQ; Huang, SQ; Kong, W; Li, XL; Liu, SJ; Lu, HQ; Lu, HY; Ni, XJ; Shang, DW; Wen, YG; Xiao, T; Yang, HL; Zhang, M; Zhu, XQ | 1 |
| Arslan, MA; Bilgici, B; Gümrükçüoğlu, Tİ; Karaustaoğlu, A; Tunçel, ÖK | 1 |
| Aguilar-Hernandez, L; Bringas, ME; Flores, G; Garcés-Ramírez, L; Lima-Castañeda, LÁ; Morales-Medina, JC | 1 |
46 review(s) available for valproic acid and olanzapine
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Management of acute mania.
Topics: Acute Disease; Algorithms; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Humans; Lithium; Olanzapine; Pirenzepine; Research Design; Risk Factors; Treatment Outcome; Treatment Refusal; Valproic Acid | 1999 |
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroconvulsive Therapy; Electromagnetic Phenomena; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2000 |
New treatments for bipolar disorder: the role of atypical neuroleptic agents.
Topics: Acute Disease; Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Antimanic Agents; Benzodiazepines; Breast Feeding; Carbamazepine; Cyclohexanecarboxylic Acids; Female; Fetus; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Infant, Newborn; Lithium; Mood Disorders; Olanzapine; Pirenzepine; Placenta; Pregnancy; Risk Factors; Valproic Acid | 2001 |
Treating acute mania.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Lithium Compounds; Olanzapine; Pirenzepine; Valproic Acid | 2003 |
Treating bipolar depression.
Topics: Acetates; Affect; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Lithium Compounds; Nipecotic Acids; Olanzapine; Oxcarbazepine; Pirenzepine; Tiagabine; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Zonisamide | 2003 |
Long-term therapy of bipolar illness.
Topics: Affect; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Humans; Lamotrigine; Lithium Compounds; Olanzapine; Pirenzepine; Secondary Prevention; Time Factors; Treatment Outcome; Triazines; Valproic Acid | 2003 |
Optimal dosing of medications (in bipolar disorder).
Topics: Acute Disease; Affect; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chronic Disease; Drug Administration Schedule; Humans; Lithium Compounds; Olanzapine; Pirenzepine; Treatment Outcome; Valproic Acid | 2003 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
[Manic phase (manic episode)].
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Electroconvulsive Therapy; Humans; Lithium; Olanzapine; Pirenzepine; Psychotherapy; Reference Standards; Valproic Acid | 2003 |
The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Tolerance; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Severity of Illness Index; Titrimetry; Treatment Outcome; Valproic Acid | 2003 |
[Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
Topics: Acute Disease; Algorithms; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Isotopes; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Triazines; Valproic Acid | 2003 |
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Valproic Acid | 2004 |
An overview of primary care assessment and management of bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic Errors; Humans; Lamotrigine; Lithium; Olanzapine; Primary Health Care; Triazines; Valproic Acid | 2004 |
Strategies for preventing the recurrence of bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Patient Education as Topic; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Triazines; Valproic Acid | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Bipolar depression: an overview.
Topics: Acute Disease; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Chemoprevention; Contraindications; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Triazines; Valproic Acid | 2004 |
Employing pharmacologic treatment of bipolar disorder to greatest effect.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Receptors, GABA; Receptors, Glutamate; Treatment Outcome; Triazines; Valproic Acid | 2004 |
Women are not the same as men: specific clinical issues for female patients with bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Counseling; Dibenzothiazepines; Family Planning Services; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Olanzapine; Pregnancy; Pregnancy Complications; Quetiapine Fumarate; Risperidone; Teratogens; Triazines; Valproic Acid; Women's Health | 2005 |
Update on the treatment of bipolar disorder in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Child; Humans; Lithium Carbonate; Olanzapine; Prospective Studies; Randomized Controlled Trials as Topic; Valproic Acid | 2005 |
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Canada; Chronic Disease; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Humans; Lamotrigine; Lithium Carbonate; Mass Screening; Mood Disorders; Olanzapine; Personality Disorders; Prevalence; Quality of Life; Risk Factors; Substance-Related Disorders; Triazines; Valproic Acid | 2005 |
Bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Chlorpromazine; Cognitive Behavioral Therapy; Humans; Lithium Carbonate; Olanzapine; Piperazines; Thiazoles; Valproic Acid | 2005 |
Management options for bipolar disorder in children and adolescents.
Topics: Adolescent; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Clozapine; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid | 2005 |
[Pharmacotherapy of manic-depressive mixed States].
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Humans; Lithium Carbonate; Olanzapine; Practice Guidelines as Topic; Treatment Outcome; Valproic Acid | 2006 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
Maintenance treatment of bipolar disorder: Applying research to clinical practice.
Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Evidence-Based Medicine; Humans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Quinolones; Triazines; Valproic Acid | 2006 |
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Databases, Bibliographic; Female; Humans; Lamotrigine; Lithium; Male; Models, Economic; Olanzapine; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic; Secondary Prevention; Triazines; Valproic Acid | 2007 |
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Double-Blind Method; Female; Haloperidol; Humans; Least-Squares Analysis; Male; Meta-Analysis as Topic; Olanzapine; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Smoking; Survival Analysis; Treatment Outcome; Valproic Acid | 2008 |
Pharmacological treatment of pathologic aggression in children.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Child; Drug Prescriptions; Health Status; Humans; Lithium Carbonate; Methylphenidate; Olanzapine; Risperidone; Time Factors; Valproic Acid; Violence | 2008 |
Rowell's syndrome in the course of treatment with sodium valproate: a case report and review of the literature data.
Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Erythema Multiforme; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Olanzapine; Pericarditis; Sertraline; Syndrome; Treatment Outcome; Valproic Acid | 2009 |
Olanzapine in long-term treatment for bipolar disorder.
Topics: Antimanic Agents; Benzodiazepines; Bipolar Disorder; Humans; Lithium Compounds; Olanzapine; Randomized Controlled Trials as Topic; Recurrence; Valproic Acid | 2009 |
Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Olanzapine; Randomized Controlled Trials as Topic; Secondary Prevention; Time Factors; Valproic Acid | 2010 |
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2010 |
Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis.
Topics: Affect; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Humans; Lithium; Lithium Carbonate; Lithium Compounds; Mood Disorders; Olanzapine; Randomized Controlled Trials as Topic; Valproic Acid | 2011 |
The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Substitution; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult | 2013 |
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Topics: Antimanic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Olanzapine; Randomized Controlled Trials as Topic; Secondary Prevention; Valproic Acid | 2013 |
Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Olanzapine; Quetiapine Fumarate; Valproic Acid | 2014 |
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Clonazepam; Diagnosis, Differential; GABA Modulators; Humans; Lithium Compounds; Male; Neuroleptic Malignant Syndrome; Olanzapine; Risperidone; Serotonin Syndrome; Valproic Acid; Young Adult | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid | 2018 |
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
Topics: Antipsychotic Agents; Anxiety; Aripiprazole; Bipolar Disorder; Canada; Humans; Olanzapine; Valproic Acid | 2021 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
Evidence-based treatment strategies for rapid cycling bipolar disorder, a systematic review.
Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Valproic Acid | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
33 trial(s) available for valproic acid and olanzapine
| Article | Year |
|---|---|
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Body Weight; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
Topics: Adult; Affective Disorders, Psychotic; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Brief Psychiatric Rating Scale; Cohort Studies; Depressive Disorder; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Treatment Outcome; Valproic Acid | 2001 |
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Topics: Acute Disease; Adult; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid | 2002 |
Olanzapine versus divalproex in the treatment of acute mania.
Topics: Acute Disease; Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; Olanzapine; Pirenzepine; Treatment Outcome; Valproic Acid | 2002 |
Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Chemotherapy, Adjuvant; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Time Factors; Valproic Acid | 2002 |
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 2003 |
A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Valproic Acid | 2002 |
Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.
Topics: Acute Disease; Adult; Ambulatory Care; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Health Care Costs; Health Services; Health Status; Humans; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Quality of Life; Treatment Outcome; Valproic Acid | 2003 |
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
Topics: Acute Disease; Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Secondary Prevention; Survival Analysis; Treatment Outcome; Valproic Acid | 2003 |
Antipsychotic-induced weight gain: bipolar disorder and leptin.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Female; Humans; Leptin; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone; Valproic Acid; Weight Gain | 2003 |
The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Tolerance; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Severity of Illness Index; Titrimetry; Treatment Outcome; Valproic Acid | 2003 |
Valproate for hostility in schizophrenia patients.
Topics: Adult; Anticonvulsants; Benzodiazepines; Female; Hostility; Humans; Male; Olanzapine; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 2004 |
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Health Services Research; Humans; Olanzapine; Placebos; Risperidone; Schizophrenia; United States; Valproic Acid | 2004 |
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
Topics: Adult; Aged; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Olanzapine; Recurrence; Time Factors; Valproic Acid | 2004 |
Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Male; Olanzapine; Placebos; Quality of Life; Treatment Outcome; Valproic Acid | 2004 |
The antidepressant effects of risperidone and olanzapine in bipolar disorder.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Weight; Chemotherapy, Adjuvant; Depression; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Time Factors; Valproic Acid | 2004 |
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Olanzapine; Treatment Outcome; Valproic Acid | 2004 |
A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Carnitine; Cocaine-Related Disorders; Coenzymes; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Ubiquinone; Valproic Acid | 2005 |
Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial.
Topics: Acute Disease; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost Savings; Double-Blind Method; Female; Health Care Costs; Health Services; Humans; Male; Middle Aged; Olanzapine; Valproic Acid | 2005 |
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Placebos; Principal Component Analysis; Psychiatric Status Rating Scales; Risk Factors; Suicide; Treatment Outcome; Valproic Acid | 2006 |
Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Topics: Adult; Aged; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Recurrence; Treatment Outcome; Valproic Acid | 2007 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid | 2007 |
A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
Topics: Administration, Oral; Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Lithium Compounds; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid | 2007 |
The Bipolar Comprehensive Outcomes Study (BCOS): baseline findings of an Australian cohort study.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Female; Health Status; Humans; Lithium Carbonate; Male; Olanzapine; Outcome Assessment, Health Care; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Severity of Illness Index; Social Adjustment; Treatment Outcome; Valproic Acid | 2008 |
Switching from other agents to extended-release carbamazepine in acute mania.
Topics: Acute Disease; Adult; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Delayed-Action Preparations; Female; Humans; Lithium Compounds; Male; Olanzapine; Valproic Acid | 2008 |
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Least-Squares Analysis; Male; Middle Aged; Olanzapine; Prolactin; Valproic Acid; Weight Gain | 2008 |
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome; Valproic Acid; Young Adult | 2009 |
Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Olanzapine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Valproic Acid | 2009 |
Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes.
Topics: Adolescent; Adult; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Female; Humans; Male; Middle Aged; Olanzapine; Predictive Value of Tests; Retrospective Studies; ROC Curve; Secondary Prevention; Single-Blind Method; Time Factors; Valproic Acid; Young Adult | 2011 |
Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antimanic Agents; Benzhydryl Compounds; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Modafinil; Olanzapine; Valproic Acid | 2010 |
A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Female; GABA Agents; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Psychotic Disorders; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Valproic Acid; Young Adult | 2011 |
Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Topics: Adult; Affect; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Japan; Lithium; Male; Middle Aged; Olanzapine; Prolactin; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Valproic Acid | 2012 |
A comparative study of beneficial effects of Olanzapine and sodium valproate on aggressive behavior of patients who are on methadone maintenance therapy: a randomized triple blind clinical trial.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Female; GABA Agents; Heroin Dependence; Humans; Male; Methadone; Olanzapine; Valproic Acid | 2013 |
113 other study(ies) available for valproic acid and olanzapine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins | 2020 |
Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Thyroxine; Valproic Acid | 1998 |
Mood stabilizer augmentation with olanzapine in acutely manic children.
Topics: Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Bipolar Disorder; Child; Drug Therapy, Combination; Humans; Lithium Chloride; Male; Olanzapine; Pirenzepine; Sleep Stages; Valproic Acid; Weight Gain | 2000 |
Possible risperidone-induced visual hallucinations.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Female; Hallucinations; Humans; Olanzapine; Pirenzepine; Risperidone; Substance-Related Disorders; Treatment Outcome; Valproic Acid | 2000 |
Improvement of Huntington's disease with olanzapine and valproate.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Huntington Disease; Male; Middle Aged; Olanzapine; Pirenzepine; Valproic Acid | 2000 |
A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Fasting; Female; Glucose Tolerance Test; Hospitalization; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Lithium; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Pirenzepine; Retrospective Studies; Risperidone; Schizophrenia; Valproic Acid | 2002 |
Quetiapine for olanzapine-induced galactorrhea.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Therapy, Combination; Female; Galactorrhea; Humans; Olanzapine; Pirenzepine; Prolactin; Quetiapine Fumarate; Valproic Acid | 2002 |
Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Male; Olanzapine; Pirenzepine; Psychomotor Agitation; Valproic Acid | 2002 |
Valproic Acid and risperidone.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Child; Drug Interactions; Humans; Olanzapine; Pirenzepine; Retrospective Studies; Risperidone; Valproic Acid | 2003 |
Nonketotic hyperosmolar syndrome from olanzapine, lithium, and valproic acid cotreatment.
Topics: Adult; Benzodiazepines; Drug Therapy, Combination; Humans; Hyperglycinemia, Nonketotic; Lithium Chloride; Male; Olanzapine; Pirenzepine; Valproic Acid | 2003 |
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obesity; Olanzapine; Pirenzepine; Risk Factors; Valproic Acid; Venlafaxine Hydrochloride | 2003 |
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Topics: Benzodiazepines; Brief Psychiatric Rating Scale; Drug Therapy, Combination; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Valproic Acid | 2003 |
Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination.
Topics: Adolescent; Alanine Transaminase; Antimanic Agents; Antipsychotic Agents; Aspartate Aminotransferases; Benzodiazepines; Child; Child, Preschool; Drug Interactions; Female; Humans; L-Lactate Dehydrogenase; Liver; Male; Olanzapine; Pancreatitis; Pirenzepine; Retrospective Studies; Valproic Acid | 2003 |
[Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Dopamine Antagonists; Drug Therapy, Combination; Haloperidol; Humans; Isotopes; Lithium; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Time Factors; Valproic Acid | 2003 |
[Long-term therapy with intuition].
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Hospitalization; Humans; Isotopes; Lithium; Olanzapine; Patient Readmission; Pirenzepine; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Valproic Acid | 2003 |
Divalproex versus olanzapine in mania.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bias; Bipolar Disorder; Clinical Trials as Topic; Humans; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid | 2003 |
Results of a naturalistic study of treatment options: switching atypical antipsychotic drugs or augmenting with valproate.
Topics: Adolescent; Adult; Age Factors; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Survival Analysis; Time Factors; Treatment Outcome; Valproic Acid | 2004 |
Successful treatment of sexual dysfunction with dronabinol: a case report.
Topics: Adult; Benzodiazepines; Bipolar Disorder; Dronabinol; Female; Humans; Libido; Olanzapine; Paroxetine; Psychotropic Drugs; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome; Valproic Acid | 2004 |
Acute psychosis with a mediastinal carcinoma metastasis.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Humans; Male; Mediastinal Neoplasms; Middle Aged; Olanzapine; Paraneoplastic Syndromes, Nervous System; Perazine; Psychotic Disorders; Valproic Acid | 2005 |
Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats.
Topics: Amitriptyline; Animals; Antidepressive Agents; Benzodiazepines; Eating; Haloperidol; Male; Olanzapine; Rats; Rats, Wistar; Self Administration; Sucrose; Valproic Acid | 2006 |
Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Temperature; Child; Dibenzothiazepines; Electroconvulsive Therapy; Female; Humans; Impulsive Behavior; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid; Violence | 2005 |
Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report.
Topics: Aged; Aggression; Alzheimer Disease; Amines; Antipsychotic Agents; Benzodiazepines; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Gabapentin; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Olanzapine; Propranolol; Quetiapine Fumarate; Risperidone; Testosterone; Trazodone; Treatment Outcome; Valproic Acid | 2005 |
Outcome measurement, outcome management and monitoring.
Topics: Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Monitoring; Humans; Lamotrigine; Lithium Carbonate; Olanzapine; Outcome and Process Assessment, Health Care; Surveys and Questionnaires; Treatment Outcome; Triazines; Valproic Acid | 2005 |
Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Personality Assessment; Randomized Controlled Trials as Topic; Treatment Outcome; Valproic Acid | 2005 |
The rational use of medications in acute psychotic presentations -- the case for less is more.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clopenthixol; Humans; Male; Olanzapine; Psychotic Disorders; Valproic Acid | 2006 |
Modification of spatial recognition memory and object discrimination after chronic administration of haloperidol, amitriptyline, sodium valproate or olanzapine in normal and anhedonic rats.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Food Preferences; Haloperidol; Male; Maze Learning; Memory; Olanzapine; Rats; Rats, Wistar; Recognition, Psychology; Space Perception; Stress, Psychological; Taste; Valproic Acid | 2007 |
A retrospective analysis of changing from alternative agents to carbamazepine extended-release capsules in bipolar disorder.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Capsules; Carbamazepine; Child; Child, Preschool; Delayed-Action Preparations; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Middle Aged; Olanzapine; Oxcarbazepine; Retrospective Studies; Treatment Outcome; Triazines; Valproic Acid | 2006 |
Valproate lowers plasma concentration of olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Mood Disorders; Olanzapine; Valproic Acid | 2006 |
Atypical antipsychotics related metabolic syndrome in bipolar patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Carbamazepine; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Prevalence; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Triazines; Valproic Acid | 2007 |
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
Topics: Acute Disease; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Canada; Comorbidity; Dibenzothiazepines; Drug Therapy, Combination; Humans; Lamotrigine; Lithium Carbonate; Mood Disorders; Olanzapine; Quetiapine Fumarate; Triazines; Valproic Acid | 2006 |
Characteristics of psychotic patients with foreign accent syndrome.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; Humans; Language; Lithium Carbonate; Magnetic Resonance Imaging; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon; Valproic Acid; Verbal Behavior | 2007 |
Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.
Topics: Adult; Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Middle Aged; Observation; Observer Variation; Olanzapine; Treatment Outcome; Triazines; Valproic Acid | 2007 |
Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Hospitalization; Humans; Lithium Carbonate; Male; Obesity; Olanzapine; Risperidone; Smoking; Valproic Acid | 2008 |
Psychopharmacology news. New side effects of agents.
Topics: Benzodiazepines; Bupropion; Female; Humans; Olanzapine; Pregnancy; Propranolol; Psychotropic Drugs; Valproic Acid | 2007 |
Risk of death associated with antipsychotic drug dispensing in residential aged care facilities.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Comorbidity; Cross-Sectional Studies; Death, Sudden; Female; Haloperidol; Homes for the Aged; Humans; Male; Nursing Homes; Olanzapine; Risk; Valproic Acid; Veterans | 2007 |
Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Cohort Studies; Dementia; Female; Haloperidol; Humans; Male; Mortality; Olanzapine; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors; Survival Rate; Valproic Acid; Veterans; Widowhood | 2007 |
Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents.
Topics: Adolescent; Adult; Aging; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Body Weight; Child; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Retrospective Studies; Risperidone; Sex Characteristics; Smoking; Tandem Mass Spectrometry; Valproic Acid | 2007 |
The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement.
Topics: Adjuvants, Immunologic; Administration, Oral; Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Central Nervous System Stimulants; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Lithium Chloride; Locomotion; Maze Learning; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Olanzapine; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Swimming; Valproic Acid | 2009 |
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model.
Topics: Adult; Algorithms; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Lamotrigine; Linear Models; Male; Middle Aged; Olanzapine; Regression Analysis; Smoking; Triazines; Valproic Acid | 2008 |
Revised Korean medication algorithm for bipolar disorder.
Topics: Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Health Personnel; Humans; Korea; Olanzapine; Psychiatry; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Valproic Acid | 2009 |
Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation.
Topics: Acetylation; Animals; Benzodiazepines; Brain; Cell Adhesion Molecules, Neuronal; Clozapine; DNA Methylation; Extracellular Matrix Proteins; Glutamate Decarboxylase; Haloperidol; Histones; Lysine; Male; Mice; Nerve Tissue Proteins; Olanzapine; Promoter Regions, Genetic; Reelin Protein; Serine Endopeptidases; Sulpiride; Valproic Acid | 2008 |
Septo-optic dysplasia and psychiatric disorders: a case report.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Septo-Optic Dysplasia; Tomography, X-Ray Computed; Valproic Acid; Visual Fields; Wechsler Scales | 2008 |
Refractory restless legs syndrome likely caused by olanzapine.
Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Piperazines; Quinolones; Restless Legs Syndrome; Valproic Acid | 2009 |
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid | 2010 |
Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Female; Gastrointestinal Diseases; Humans; Male; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Valproic Acid; Weight Gain | 2009 |
Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.
Topics: Affect; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Dibenzothiazepines; Double-Blind Method; Fluoxetine; Health Status; Humans; Markov Chains; Olanzapine; Quality-Adjusted Life Years; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Valproic Acid | 2009 |
Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.
Topics: Adult; Aging; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Smoking; Time Factors; Valproic Acid; Young Adult | 2009 |
Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Blood Glucose; Body Mass Index; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Insulin; Lithium Carbonate; Male; Obesity; Olanzapine; Overweight; Prospective Studies; Quetiapine Fumarate; Risperidone; Triglycerides; Valproic Acid; Weight Gain; Young Adult | 2010 |
The role of divalproex plus olanzapine in outpatient mixed-episode bipolar I disorder.
Topics: Ambulatory Care; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Humans; Olanzapine; Prospective Studies; Randomized Controlled Trials as Topic; Secondary Prevention; Valproic Acid | 2009 |
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Dibenzothiazepines; Electroconvulsive Therapy; Humans; Lamotrigine; Lithium Compounds; Olanzapine; Psychiatric Status Rating Scales; Psychotherapy; Quetiapine Fumarate; Triazines; Valproic Acid | 2010 |
Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Ethnicity; Female; Humans; Lithium Carbonate; Male; Observation; Olanzapine; Personality Disorders; Prospective Studies; Quetiapine Fumarate; Remission Induction; Risperidone; Severity of Illness Index; Substance-Related Disorders; Valproic Acid | 2010 |
Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Citrate (si)-Synthase; Electron Transport; Electron Transport Complex I; Electron Transport Complex III; Electron Transport Complex IV; In Vitro Techniques; Lithium Compounds; Mitochondria; Olanzapine; Swine; Valproic Acid | 2010 |
Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Topics: Absenteeism; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Fees, Pharmaceutical; Health Care Costs; Hospital Charges; Humans; Lamotrigine; Lithium Compounds; Markov Chains; Models, Economic; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quetiapine Fumarate; Quinolones; Risk; Tablets; Triazines; United States; Valproic Acid | 2010 |
Efficacy of olanzapine and sodium valproate given alone or as add-on therapy in acute mania. A comparative study.
Topics: Acute Disease; Adult; Aged; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Valproic Acid | 2010 |
Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Metabolic Clearance Rate; Olanzapine; Risperidone; Valproic Acid | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Symptoms of agitated depression and/or akathisia.
Topics: Affective Disorders, Psychotic; Akathisia, Drug-Induced; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Diagnosis, Differential; Diagnostic Errors; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Middle Aged; Olanzapine; Psychomotor Agitation; Quetiapine Fumarate; Valproic Acid | 2011 |
Folie à deux: double case-report of shared delusions with a fatal outcome.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Clozapine; Combined Modality Therapy; Epilepsy; Fatal Outcome; Female; Haloperidol; Humans; Nordazepam; Olanzapine; Patient Compliance; Psychotherapy; Psychotic Disorders; Schizophrenia, Paranoid; Shared Paranoid Disorder; Sibling Relations; Suicide; Valproic Acid | 2011 |
Predictors of relapse or recurrence in bipolar I disorder.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Olanzapine; Prognosis; Recurrence; Valproic Acid | 2012 |
Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cohort Studies; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Practice Patterns, Physicians'; Primary Health Care; Quetiapine Fumarate; Retrospective Studies; Social Class; Time Factors; United Kingdom; Valproic Acid | 2011 |
Risk of mortality among individual antipsychotics in patients with dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Olanzapine; Propensity Score; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone; Time Factors; Valproic Acid | 2012 |
Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Liver Function Tests; Neutropenia; Olanzapine; Retreatment; Thrombocytopenia; Valproic Acid | 2012 |
Acute overdose of enteric-coated valproic acid and olanzapine: unusual presentation and delayed toxicity.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Drug Overdose; Female; Humans; Olanzapine; Tablets, Enteric-Coated; Valproic Acid | 2012 |
Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Humans; Kaplan-Meier Estimate; Male; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone; Valproic Acid | 2012 |
Valproic Acid significantly lowers serum concentrations of olanzapine-an interaction effect comparable with smoking.
Topics: Adult; Age Factors; Anticonvulsants; Benzodiazepines; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Retrospective Studies; Smoking; Valproic Acid | 2012 |
Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Australia; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Outpatients; Practice Patterns, Physicians'; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Recurrence; Valproic Acid | 2012 |
Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Haloperidol; Humans; Influenza A Virus, H1N1 Subtype; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Pneumonia, Viral; Schizophrenia; Treatment Outcome; Valproic Acid; Withholding Treatment | 2013 |
Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
Topics: Adolescent; Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Case-Control Studies; Clozapine; Cohort Studies; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Evidence-Based Medicine; Female; Hospitalization; Humans; Lithium Carbonate; Male; Middle Aged; Multivariate Analysis; Olanzapine; Pneumonia; Propensity Score; Risk Factors; Taiwan; Valproic Acid; Young Adult | 2013 |
Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Carbamazepine; Causality; Dibenzothiazepines; Drug-Related Side Effects and Adverse Reactions; Female; Galactorrhea; Humans; Lamotrigine; Logistic Models; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Switzerland; Triazines; Valproic Acid; Weight Gain; Young Adult | 2013 |
Exacerbation of mood symptoms associated to primary and secondary carnitine deficiency: a case report.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Carnitine; Citalopram; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Drug Substitution; Drug Therapy, Combination; Humans; Hyperammonemia; Ketoglutarate Dehydrogenase Complex; Lorazepam; Male; Mood Disorders; Olanzapine; Organic Cation Transport Proteins; Solute Carrier Family 22 Member 5; Valproic Acid | 2013 |
Bipolar disorder in Pendred syndrome: a case report of two siblings.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Female; Goiter, Nodular; Hearing Loss, Sensorineural; Humans; Olanzapine; Siblings; Thyroxine; Treatment Outcome; Valproic Acid; Young Adult | 2014 |
An atypical case of neuroleptic malignant syndrome precipitated by valproate.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Levetiracetam; Lorazepam; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Piracetam; Pramipexole; Psychotic Disorders; Valproic Acid | 2014 |
[Association of atypical neuroleptics with anticonvulsants and malignant syndrome. Report of 2 cases].
Topics: Adolescent; Adult; Amisulpride; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Drug Therapy, Combination; Female; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; Sulpiride; Valproic Acid | 2014 |
[Hemoperfusion with activated charcoal on valproic acid poisoning. A case report].
Topics: Benzodiazepines; Charcoal; Combined Modality Therapy; Depressive Disorder; Drug Overdose; Female; Flumazenil; Hemoperfusion; Humans; Hyperammonemia; Middle Aged; Naloxone; Olanzapine; Paranoid Disorders; Psychotropic Drugs; Respiration, Artificial; Suicide, Attempted; Valproic Acid | 2015 |
The effects of valproate and olanzapine on the abnormal behavior of diacylglycerol kinase β knockout mice.
Topics: Animals; Anxiety; Benzodiazepines; Cognition Disorders; Diacylglycerol Kinase; Disease Models, Animal; Drug Therapy, Combination; Male; Maze Learning; Mice; Mice, Knockout; Motor Activity; Olanzapine; Valproic Acid | 2015 |
Pulmonary embolism in a psychiatric patient.
Topics: Adult; Aggression; Antipsychotic Agents; Autopsy; Benzodiazepines; Bipolar Disorder; Catatonia; Death, Sudden; Female; Humans; Hypothyroidism; Incidence; Lorazepam; Obesity; Olanzapine; Ovarian Neoplasms; Patient Admission; Patient Transfer; Pulmonary Embolism; Restraint, Physical; Risk; Valproic Acid; Venous Thrombosis | 2014 |
Phosphorylation of transcription factor specificity protein 4 is increased in peripheral blood mononuclear cells of first-episode psychosis.
Topics: Adolescent; Adult; Animals; Antipsychotic Agents; Benzodiazepines; Cells, Cultured; Cross-Sectional Studies; Female; Humans; Lithium; Male; Models, Biological; Neurons; Olanzapine; Phosphorylation; Pilot Projects; Psychotic Disorders; Rats; Serine; Sp4 Transcription Factor; Valproic Acid; Young Adult | 2015 |
Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Valproic Acid | 2015 |
Treatment of comorbid bipolar disorder and anxiety disorders: A great challenge to modern psychiatry.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Comorbidity; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Valproic Acid | 2016 |
Changes in mood stabilizer prescription patterns in bipolar disorder.
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Prescriptions; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Sweden; Valproic Acid | 2016 |
Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
Topics: Adult; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Cohort Studies; Cross-Sectional Studies; Electronic Health Records; Female; Humans; Lithium Carbonate; Longitudinal Studies; Male; Middle Aged; Olanzapine; Propensity Score; Quetiapine Fumarate; Self-Injurious Behavior; Suicide; Treatment Outcome; United Kingdom; Valproic Acid; Wounds and Injuries | 2016 |
Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypercalcemia; Hypertension; Lithium Compounds; Longitudinal Studies; Male; Middle Aged; Olanzapine; Propensity Score; Quetiapine Fumarate; Renal Insufficiency; Thyroid Diseases; Valproic Acid | 2016 |
Pharmacological agents to reduce readmissions in bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Lithium Compounds; Olanzapine; Patient Readmission; Randomized Controlled Trials as Topic; Valproic Acid | 2017 |
Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Cohort Studies; Drug Therapy, Combination; Female; Hospitalization; Humans; Lithium Compounds; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Registries; Secondary Prevention; Valproic Acid; Young Adult | 2017 |
Chlorpheniramine dependence presenting as mania.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Chlorpheniramine; Diagnosis, Differential; GABA Agents; Histamine H1 Antagonists; Humans; Male; Olanzapine; Substance-Related Disorders; Valproic Acid | 2017 |
DRESS syndrome: Addressing the drug hypersensitivity syndrome on combination of Sodium Valproate and Olanzapine.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Humans; Male; Olanzapine; Valproic Acid | 2017 |
Severe recurrent hypothermia in an elderly patient with refractory mania associated with atypical antipsychotic, valproic acid and oxcarbazepine therapy.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Hypothermia; Olanzapine; Oxcarbazepine; Quetiapine Fumarate; Recurrence; Valproic Acid | 2017 |
Second-generation antipsychotic and diabetes mellitus in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Benzodiazepines; Blood Glucose; Clomipramine; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Insulin; Lithium; Male; Metformin; Olanzapine; Valproic Acid | 2017 |
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Topics: Adolescent; Aged; Algorithms; Antipsychotic Agents; Bipolar Disorder; Bupropion; Child; Evidence-Based Medicine; Female; Humans; Lamotrigine; Lithium Compounds; Olanzapine; Quetiapine Fumarate; Societies, Medical; Suicide; Suicide Prevention; Valproic Acid | 2018 |
Harmala Alkaloids Identify Ayahausca Intoxication in a Urine Drug Screen.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Banisteriopsis; Chromatography, Liquid; Hallucinogens; Harmala Alkaloids; Humans; Male; Mass Spectrometry; N,N-Dimethyltryptamine; Olanzapine; Plant Extracts; Psychoses, Substance-Induced; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome; Valproic Acid | 2019 |
Failure of rechallenge clozapine after agranulocytosis: A case report.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Clopenthixol; Clozapine; Drug Resistance; Drug Substitution; Drug Synergism; Drug Therapy, Combination; Humans; Male; Olanzapine; Schizophrenia, Paranoid; Valproic Acid | 2019 |
Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate.
Topics: Adult; Antipsychotic Agents; Cohort Studies; Drug Combinations; Drug Interactions; Female; Humans; Lithium Carbonate; Male; Naltrexone; Narcotic Antagonists; Olanzapine; Valproic Acid; Weight Gain; Young Adult | 2020 |
Generalised tonic-clonic seizures on the subtherapeutic dose of olanzapine.
Topics: Administration, Intravenous; Aged; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Drug Monitoring; Electroencephalography; Humans; Male; Olanzapine; Risk Factors; Seizures; Treatment Outcome; Valproic Acid | 2019 |
A Retrospective Analysis of Steady-State Olanzapine Concentrations in Chinese Patients Using Therapeutic Drug Monitoring: Effects of Valproate and Other Factors.
Topics: Adolescent; Adult; Antipsychotic Agents; Asian People; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Retrospective Studies; Schizophrenia; Sex Factors; Smoking; Valproic Acid; Young Adult | 2020 |
Factors Affecting Serum Olanzapine Concentration.
Topics: Antipsychotic Agents; Benzodiazepines; China; Drug Monitoring; Humans; Olanzapine; Retrospective Studies; Valproic Acid | 2021 |
Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram.
Topics: Antipsychotic Agents; Bipolar Disorder; Citalopram; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Valproic Acid; Venlafaxine Hydrochloride | 2021 |
Inpatient treatment of anorexia nervosa with adjunctive valproate: a case series of 14 young and adolescent patients.
Topics: Adolescent; Anorexia Nervosa; Child; Hospitalization; Humans; Inpatients; Olanzapine; Valproic Acid | 2022 |
Lurasidone-Induced Manic Switch in an Adolescent with Bipolar I Disorder: a Case Report.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Lurasidone Hydrochloride; Male; Mania; Olanzapine; Quetiapine Fumarate; Valproic Acid | 2021 |
Effect of CYP2C19 polymorphisms on serum valproic level acid in Chinese Han patients with schizophrenia.
Topics: Adult; Alleles; Anticonvulsants; Asian People; China; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Male; Mass Spectrometry; Middle Aged; Olanzapine; Pharmacogenetics; Polymorphism, Single Nucleotide; Real-Time Polymerase Chain Reaction; Regression Analysis; Schizophrenia; Valproic Acid; Young Adult | 2021 |
Increased growth hormone secretagogue receptor-1a (GHSR-1a) in hypothalamus during olanzapine treatment in rats.
Topics: Adiponectin; Animals; Ghrelin; Hypothalamus; Interleukin-6; Leptin; Olanzapine; Rats; Receptors, Ghrelin; Resistin; Tumor Necrosis Factor-alpha; Valproic Acid; Weight Gain | 2022 |
Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Female; Humans; Male; Mental Disorders; Middle Aged; Mirtazapine; Off-Label Use; Olanzapine; Psychiatry; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone; Valproic Acid | 2022 |
Population pharmacokinetics and dosing optimization of olanzapine in Chinese paediatric patients: Based on the impact of sex and concomitant valproate on clearance.
Topics: Adult; Aged; Antipsychotic Agents; Child; China; Female; Humans; Kinetics; Male; Models, Biological; Olanzapine; Valproic Acid | 2022 |
Increased levels of lipid and protein oxidation in rat prefrontal cortex after treatment by lithium, valproic acid, and olanzapine.
Topics: Advanced Oxidation Protein Products; Animals; Antipsychotic Agents; Benzodiazepines; Lithium; Male; Olanzapine; Prefrontal Cortex; Rats; Rats, Wistar; Valproic Acid | 2023 |
The antipsychotic olanzapine reduces memory deficits and neuronal abnormalities in a male rat model of Autism.
Topics: Animals; Antipsychotic Agents; Autism Spectrum Disorder; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Female; Humans; Male; Memory Disorders; Neurons; Olanzapine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Social Behavior; Valproic Acid | 2023 |